There’s Still Time to Buy Lipella Pharmaceuticals Inc (NASDAQ:LIPO) Stock

The price of Lipella Pharmaceuticals Inc (NASDAQ:LIPO) shares last traded on Wall Street rose 6.44% to $0.46.

LIPO stock price is now 5.10% away from the 50-day moving average and -32.43% away from the 200-day moving average. The market capitalization of the company currently stands at $3.66M.

Top 5 Artificial Intelligence Stocks to Buy for 2024

By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it. According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."

Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"

Sponsored

In other news, Kaufman Jonathan H, insider bought 10,000 shares of the company’s stock on May 14 ’24. The stock was bought for $7,590 at an average price of $0.76. Upon completion of the transaction, the insider now directly owns 898,849 shares in the company, valued at $0.41 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 18 ’24, below. Kaufman Jonathan H bought 30,000 shares of the business’s stock. A total of $23,649 was incurred on buying the stock at an average price of $0.79. This leaves the insider owning 863,849 shares of the company worth $0.4 million. A total of 35.49% of the company’s stock is owned by insiders.

During the past 12 months, Lipella Pharmaceuticals Inc has had a low of $0.32 and a high of $2.71. As of last week, the company has a debt-to-equity ratio of 0.05, a current ratio of 4.33, and a quick ratio of 4.33. The fifty day moving average price for LIPO is $0.43858 and a two-hundred day moving average price translates $0.68023 for the stock.

The latest earnings results from Lipella Pharmaceuticals Inc (NASDAQ: LIPO) was released for 2024-06-30. The net profit margin was -816.71% and return on equity was -171.56% for LIPO. The company reported revenue of $0.14 million for the quarter, compared to $0.11 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 27.1 percent.

Related Posts